Provision of Clinical Trial Monitoring to the FaR-RMS Trial

Tender for the Provision of Clinical Trial Monitoring to the FaR-RMS Trial · Closed

Buyer
Tender for the Provision of Clinical Trial Monitoring to the FaR-RMS Trial
Status
Closed
Country
United Kingdom
Region
England
Sector
Professional Services
Reference
FaT-ocds-h6vhtk-02a184
Published
2021-03-31
Deadline
2021-04-30

Tender summary

The FaR-RMS trial The University of Birmingham Cancer Research Clinical Trials Unit are working on a collaboration with a large Pharmaceutical company to add a new arm to an existing study. The trial is a multicentre, randomised phase II trial evaluating the new therapy against a control arm in paediatric patients with relapsed/refractory rhabdomyosarcoma. Patients will receive therapy for up to 12 cycles (approx. 12 months) and will be followed-up for 5 years.

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap